Fundraising FoxSCI Ventures
Venture capitalLondon · Seed–Series B · 18 people tracked
Find your way into SCI Ventures
Sign up to see every warm intro you have to SCI Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SCI Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
SCI Ventures is a dedicated venture fund focused on accelerating cures and treatments for paralysis, starting with spinal-cord injury and related markets. Backed by leading paralysis research foundations and clinical centers, the fund brings together investors, entrepreneurs, clinicians and neuroscientists. It invests globally in early-stage companies — typically Seed through Series B — that are built around rigorous, innovative scientific advancements with the greatest potential to impact people living with spinal cord injury. Its aim is to move therapies from the lab to the clinic faster, catalyzing both symptomatic and curative treatments for neurological conditions.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & public directories
Founder mafia
3 people who came through SCI Ventures went on to found or lead other companies.
What they invest in
from 9 of 16 portfolio companiesBiotech ×4Deep Tech ×4Digital Health ×3Fintech ×3Healthtech ×3AI & Machine Learning ×2Medical Devices ×2E-commerce ×1
HQs:India×3United States×3France×1United Kingdom×1
Investments · 16 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12021 · 13 dated
Groww is an investment platform that allows users to buy and sell exchange-traded funds (ETFs) through an online portal.
FintechBengaluru, IN
Lalit Keshre(CEO)inIshan Bansal(Founder)inHarsh Jain(COO)inNeeraj Singh(Founder)in
BoardAnu Hariharan(Director)inAshish Agrawal(Nominee Director)
Co-investorsAlkeon InnovationEnsemble VCFrialeICONIQInsignia Ventures PartnersPeak XV Partners+11 more
NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.
BiotechDeep TechHealthtechMedical Devices
Harold Punnett(Co-founder)inJerry Silver(Co-founder)William Adams(Executive Officer)Paul Brennan(Director, Executive Officer)inDaniel Mikol(Executive Officer)inAdam Rogersin
Co-investorsCWRU Technology Ventures
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsSofinnova VenturesvenBio PartnersMRL Ventures FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+8 more
Bik.ai builds an AI-powered CRM platform for ecommerce brands to manage marketing, customer support, and sales through conversational AI agents.
AI & Machine LearningE-commerceEnterprise SoftwareSaaSSan Francisco, US
Sonakshi Nathani(Founder)inAshutosh Singla(Founder)inASHUTOSH SINGLA(Founder)inAnushka Saha(Recruiter)Harika Bondili(Recruiter)
Co-investorsPioneerY CombinatorMantis CapitalPeak XV PartnersVenture Investment AssociatesVentureSouq
Cyllene Therapeutics is a biotechnology company developing "pinpoint gene therapy" using a non-replicative HSV-1 based vector platform to deliver disease-modifying transgenes for peripheral nervous system disorders.
BiotechDeep TechDigital HealthParis, FR
Philippe Chambon MD, PhD(Founder)inPhilippe Chambon(Founder, Chairman & CEO)Alberto Epstein(Founder & CSO)Cornelia Haag-Molkenteller(CMO)Samuel Salot(COO)Marc Grasso(CFO)
Co-investorsBpifranceM VenturesAndera Partners
Drip provides trade financing and working capital solutions for small and midsize businesses conducting cross-border commerce, using automated underwriting and transaction processing to assess credit and connect borrowers with capital providers and logistics partners.
FintechMH, IN
Pushkar Mukewar(CEO)inNeil Kothari(CEO)Yash Kothari(New Business Development)inNaqiyah Sohagpurwalla(Recruiter)Chanchal Singh(HR Lead)
Co-investorsAccelBetter Tomorrow VenturesBragiel BrothersDYDX CapitalEndeavor8GMO VenturePartners+19 more
Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence.
AI & Machine LearningBiotechDigital HealthHealthtechCambridge, GB
Tim Guilliams(Founder)inDr David Brown(Co-Founder and Board member)inDavid J. Brown(Founder)in
Co-investorsAmadeus Capital PartnersAurum Venture PartnersBalderton CapitalCambridge Angels groupDaniel GutenbergGlobal Brain+4 more
Khatabook provides a mobile app that allows business owners to digitally record customer credit and debit transactions, replacing paper ledgers; the platform also offers access to lending services and is designed for small businesses managing customer accounts.
FintechBengaluru, IN
Ravish Naresh(CEO)inAshish Sonone(Founder)Gaurav Lahoti(Founder)Jaideep Poonia(Founder)Rishabh Gupta(Founder)Vaibhav Kalpe(Founder)
Co-investorsAlkeon InnovationAlpha Wave GlobalAngel Collective Opportunity FundB Capital GroupB4 CapitalBetter Capital+29 more
.jpeg){kind=logo}
Precision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts.
Deep TechDigital HealthHealthtechMedical DevicesNew York, US
Benjamin Rapoport(President, Chief Science Officer)inMichael Mager(Chief Executive Officer)inCraig Mermel(President and Chief Product Officer)inMIchael Kaswan(Chief Financial Officer)Konstantinos Alataris(President)inBenjamin Rapoport Michael Mager(Founder)
Co-investorsAlumni VenturesB Capital GroupB4 CapitalBasecamp FundDraper AssociatesForepont Capital Partners+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AugmentalAxonisCraighospitalEgOnwardOnward MedicalSania Therapeutics
Exits · 2
2 IPOsGrowwNSE: GROWWNervGen PharmaNASDAQ: NGEN
Portfolio news
latest coverage across their companiesBIK · ycombinator.com · Oct 22, 2025
Frequently asked questions
- How many investments has SCI Ventures made?
- SCI Ventures has 16 tracked investments, 2 of which have exited, including 2 dated in the last 24 months.
- What stage does SCI Ventures invest at?
- SCI Ventures invests at the Seed, Series A, Series B stages.
- What sectors does SCI Ventures focus on?
- SCI Ventures focuses on Biotech, Deep Tech, Healthtech, Impact & Social Good, Medical Devices.
- Where is SCI Ventures located?
- SCI Ventures is headquartered in London, GB.
- Who does SCI Ventures co-invest with?
- SCI Ventures most often shares deals with Amadeus Capital Partners, B Capital Group, Balderton Capital, among 28 tracked co-investors.
Images
Similar investors
Asabys Partners is an investment firm based in Barcelona focused on healthcare and life-sciences innovation.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.
The Brabantse Ontwikkelings Maatschappij (BOM) is the regional development agency for the Dutch province of Brabant, providing capital, knowledge, and network support to startups and scale-ups while helping companies expand internationally and attracting foreign firms to the region.
DBH is a Hungary-based group offering venture capital investment, corporate business services (finance, accounting, payroll, tax advisory), innovation support through DBH InnoHub, and commercial/serviced office properties. Its venture capital arm backs entrepreneurs addressing global challenges and sustainable development.
MaRS Discovery District is Canada's anchor innovation hub, based in Toronto, that supports startups and scale-ups with commercialization guidance, connections to capital, customers and talent, and access to a network of advisors, researchers and partners.